Intrinsic Value

Regulus Therapeutics Inc. (RGLS)

$ 0.411
+0.02 (+4.85%)

Enterprise Value -697,877,446,101.19
Net Debt -26.43
Equity Value -697,877,446,074.76
Shares Outstanding 71.29
Equity Value Per Share -9,789,149,384.71

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt